Chen Jishun – Trademark Portfolio

Entity Type: 01

Chen Jishun holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 8 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include AKIHOO and OTXUGK. The owner is based in XiaMen.

SiMing District QianPu Mid Road #211

XiaMen 361000 , CN

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OTXUGK
OTXUGK
Registered 2024
AIMICO
AIMICO
Cancelled 2018
CALOER
CALOER
Cancelled 2018
BOLOMI
BOLOMI
Cancelled 2018
GOCHIC
GOCHIC
Cancelled 2018
AKIHOO
AKIHOO
Registered 2018
MIDOSOO
MIDOSOO
Cancelled 2018
NEKOSI
NEKOSI
Cancelled 2018
YAKITA
YAKITA
Cancelled 2018

Trademark Classifications

Chen Jishun's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (8 filings)

Clothing, footwear, headgear

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Chen Jishun have?

Chen Jishun has 9 U.S. trademarks filed with the USPTO. Of these, 2 registered, 7 cancelled.

What trademark classes does Chen Jishun file in?

Chen Jishun files trademarks across 2 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 10 (Medical Apparatus). Class 25 covers clothing, footwear, headgear.

What are Chen Jishun's most well-known trademarks?

Chen Jishun's registered trademark portfolio includes well-known marks such as AKIHOO and OTXUGK. These are among 2 currently registered trademarks in the portfolio.

What is Chen Jishun's trademark registration success rate?

Chen Jishun has a 22% trademark registration rate, with 2 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.